ASTRAZEN - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.2

💊 AstraZeneca Pharma India shows strong technical momentum and institutional support, making it a favorable candidate for intraday trading with caution on valuation and volume.

📈 Positive

• 🔹 MACD at 142: Strong bullish crossover supports continued upward momentum.
• 🔹 RSI at 62.8: Bullish zone, indicating active buying interest.
• 🔹 Price Above 50 & 200 DMA: Current price (₹9,589) is above both DMAs (₹9,165 & ₹8,506), confirming trend strength.
• 🔹 ROCE at 33.4% & ROE at 23.6%: Excellent capital efficiency and shareholder returns.
• 🔹 DII Accumulation: Domestic institutional holdings increased by 0.71%, signaling confidence.
• 🔹 EPS of ₹73.3: Reflects strong earnings base.

⚠️ Limitation

• 🔸 High P/E Ratio: At 113, significantly above industry average (33.1), suggesting valuation premium.
• 🔸 PEG Ratio at 2.62: Indicates expensive growth expectations.
• 🔸 FII Outflow: Foreign institutional holdings declined by 0.29%.
• 🔸 Volume Flat: Current volume (18.6K) is nearly equal to 1-week average (17.8K), showing stable but not surging interest.
• 🔸 Quarterly PAT Dip: Slight decline from ₹62.3 Cr to ₹56.1 Cr.

🚫 Company Negative News

• 📉 Profitability Pressure: Analysts cite regulatory delays and pricing controls affecting margins in key therapeutic areas.

✅ Company Positive News

• 🧬 Pipeline Strength: Continued investment in oncology and respiratory portfolios with new launches expected.
• 📈 Quarterly Profit Growth: 60.1% YoY variation shows strong operational performance.

🏦 Industry

• 🩺 Sector: Pharmaceuticals — Specialty & Branded Formulations.
• 📊 Industry PE: 33.1, lower than ASTRAZEN’s, indicating valuation caution.

📌 Conclusion

• 📉 Intraday Setup: Strong MACD, RSI, and DMA support favor breakout trades; valuation and volume caution apply.
• 💰 Optimal Buy Price: ₹9,560–₹9,580 (on minor dips).
• 📈 Profit Exit Level: ₹9,640–₹9,680 (short-term resistance zone).
• 🛑 Stop Loss: ₹9,520 (below 50 DMA).
• ⏳ If Holding: Exit if RSI crosses 65 or price fails to hold above ₹9,580 intraday.

I can also compare ASTRAZEN’s intraday setup with other pharma stocks showing similar MACD and ROCE strength today.